Skip to main content

Table 1 General data of patients combined with renal TMA and lupus nephritis

From: The spectrum of renal thrombotic microangiopathy in lupus nephritis

No. Age (years) Clinical diagnosis Pathological types CFH (μg/ml) ACL Anti-β2GP-1 ADAMTS-13 Activity (%) C4d deposition on vascular wall
1 25 LN IV-G(A/C) 386.0 - - 88 -
2 38 LN IV-G(A/C) 670.2 - - 83 ++
3 34 LN IV-G(A) 166.8 - - 70 +
4 45 LN+MHT IV-G(A/C) 694.8 - - 68 -
5 28 LN IV-G(A/C) 298.8 - - 94 +
6 43 LN IV-G(A)+V 642.8 - - 75 -
7 26 LN+Scleroderma IV-G(A) 136.0 - - 74 +
8 26 LN IV-G(A)+V 112.8 - - 95 -
9 23 LN IV-G(A)+V 385.4 - - 91 +
10 27 LN+TTP-HUS IV-G(A/C) 146.0 - - 97 +
11 32 LN III(A/C)+V 467.6 - - 95 +
12 38 LN+MHT IV-G(A/C) 251.6 - - 98 -
13 20 LN IV-G(A) 362.4 - - 98 -
14 31 LN IV-G(A) 551.2 - - 71 -
15 25 LN IV-G(A) 567.4 - - 85 +
16 19 LN IV-G(A) 620.4 - - 98 +
17 34 LN+TTP-HUS IV-G(A) 365.6 - - 89 -
18 19 LN IV-S(A) 457.0 - - 89 -
19 31 LN IV-G(A) 491.4 - - 97 -
20 18 LN+APS IV-G(A)+V 162.0 + - 45 +
21 30 LN+APS V 707.2 - + 98 +
22 43 LN III(A/C)+V 498.8 - - 96 +
23 24 LN IV-G(A/C) 222.4 - - 96 +
24 35 LN IV-G(A/C) 540.0 - - 99 -
25 40 LN IV-G(A/C) 117.8 - - 98 -
26 21 LN III 201.2 - - 63 +
27 38 LN IV-G(A) 672.6 - - 88 +
28 52 LN IV-G(A/C) 131.0 - - 96 -
29 37 LN V 340.0 - - 32 -
30 27 LN IV-G(A) 124.4 - - 95 -
31 18 LN IV-G(A/C) 492.8 - - 95 -
32 15 LN IV-G(A) 221.2 - - 97 ++
33 33 LN IV-G(A) 374.0 - - 80 +
34 15 LN IV-G(A) 407.2 - - 68 +
35 40 LN V 434.2 - - 96 -
36 20 LN IV-G(A) 627.6 - - 97 +
  1. Note: The normal range of serum CFH was 561.3 ± 179.7 (381.6 to 741.0) μg/ml. The normal range of ADAMTS-13 activity was 95% (42% to 99%). Abbreviations: APS, anti-phospholipid syndrome; LN, lupus nephritis; MHT, malignant hypertension; TTP-HUS, thrombotic thrombocytopenic purpura-hemolytic uremic syndrome